The pathological practice for metastatic carcinoma of unknown primary - The current status and future prospect

Mika Watanabe

Research output: Contribution to journalArticlepeer-review

Abstract

The pathological practice for metastatic carcinoma of unknown primary is mainly to decide the histological type and suggestive primary site, which are very important for the therapeutic approach. In addition, for the morphological features with ordinary hematoxylin-eosin (HE) staining, one of the most universal and important methods is immunohistochemical staining. In recent years, detailed investigations could be performed with the combination of various primary antibodies with high organ specificity, a different pattern or amount of expression in each organ, although some cases, especially those of poor to undifferentiated carcinomas, have remained unindentified.

Original languageEnglish
Pages (from-to)910-914
Number of pages5
JournalJapanese Journal of Cancer and Chemotherapy
Volume36
Issue number6
Publication statusPublished - 2009 Jun

Keywords

  • Immunohistochemistry
  • Pathology
  • Primary antibody

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'The pathological practice for metastatic carcinoma of unknown primary - The current status and future prospect'. Together they form a unique fingerprint.

Cite this